Company Name: |
Daicel Chiral Technologies (China)CO.,LTD
|
Tel: |
021-50460086-9 15921403865 |
Email: |
han_yajun@dctc.daicel.com |
Products Intro: |
Product Name:4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione CAS:2093386-50-4 Purity:95% Package:250mg;1g Remarks:209637
|
Company Name: |
Sichuan Wei Keqi Biological Technology Co., Ltd.
|
Tel: |
028-81700200 18116577057 |
Email: |
3003855609@qq.com |
Products Intro: |
Product Name:Thalidomide-NH-C6-NH2 CAS:2093386-50-4 Purity:98% Package:5mg;10mg;20mg;50mg;100mg;200mg;500mg;1g
|
|
| 4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl Basic information |
Product Name: | 4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl | Synonyms: | 4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl;Thalidomide-NH-C6-NH2;1H-Isoindole-1,3(2H)-dione, 4-[(6-aminohexyl)amino]-2-(2,6-dioxo-3-piperidinyl)-;4-[(6-Aminohexyl)amino]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;Thalidomide-4-NH-C6-NH2;4-[(6-aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione | CAS: | 2093386-50-4 | MF: | C19H24N4O4 | MW: | 372.42 | EINECS: | | Product Categories: | | Mol File: | 2093386-50-4.mol | ![4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl Structure](CAS/20200401/GIF/2093386-50-4.gif) |
| 4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl Chemical Properties |
Boiling point | 648.2±55.0 °C(Predicted) | density | 1.342±0.06 g/cm3(Predicted) | pka | 10.75±0.40(Predicted) |
| 4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl Usage And Synthesis |
Biological Activity | Thalidomide-NH-C6-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. | References | [1]. Wang Z, et al. Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands. J Med Chem. 2019 Sep 12;62(17):8152-8163. |
| 4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl Preparation Products And Raw materials |
|